Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 26;10(3):e758.
doi: 10.1002/osp4.758. eCollection 2024 Jun.

The effects of weight loss interventions on children and adolescents with non-alcoholic fatty liver disease: A systematic review and meta-analysis

Affiliations
Review

The effects of weight loss interventions on children and adolescents with non-alcoholic fatty liver disease: A systematic review and meta-analysis

Mohammad Hassan Sohouli et al. Obes Sci Pract. .

Abstract

Background: Overall, there is conflicting evidence regarding the beneficial effects of optimal lifestyle modification, particularly weight loss interventions, with nonalcoholic fatty liver disease (non-alcoholic fatty liver disease (NAFLD)). Therefore, this study investigated the effects of weight loss interventions on laboratory and clinical parameters in children and adolescents with NAFLD.

Methods: Original databases (PubMed/MEDLINE, Web of Science, SCOPUS, and Embase) were searched using standard keywords to identify all controlled trials investigating the effects of weight loss interventions among NAFLD children and adolescents. Pooled weighted mean difference and 95% confidence intervals were achieved by random-effects model analysis.

Results: Eighteen eligible clinical trials were included in this systematic review and meta-analysis. The pooled findings showed that especially more intense weight loss interventions significantly reduced the glucose (p = 0.007), insulin (p = 0.002), homeostatic model assessment-insulin resistance (HOMA-IR) (p = 0.003), weight (p = 0.025), body mass index (BMI) (p = 0.003), BMI z-score (p < 0.001), waist circumference (WC) (p = 0.013), triglyceride (TG) (p = 0.001), and aspartate transaminase (AST) (p = 0.027). However, no significant changes were found in total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), alanine transaminase (ALT), and hepatic steatosis grades (all p > 0.05) following weight loss interventions.

Conclusions: Weight loss interventions had significant effects on NAFLD-related parameters including glucose, insulin, HOMA-IR, weight, BMI, BMI z-score, WC, TG, and AST.

Keywords: adolescent; anthropometry; children; glycemic index; lipid profile; liver profile; non‐alcoholic fatty liver disease; weight loss.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

FIGURE 1
FIGURE 1
Flowchart of the study.
FIGURE 2
FIGURE 2
Forest plots from the meta‐analysis of clinical trials investigating the effects of weight loss interventions on (A) glucose, (B) insulin, and (C) homeostatic model assessment‐insulin resistance (HOMA‐IR). HOMA‐IR, homeostatic model assessment‐insulin resistance; WMD, weighted mean difference.
FIGURE 3
FIGURE 3
Forest plots from the meta‐analysis of clinical trials investigating the effects of weight loss interventions on (A) weight, (B) BMI, (C) body mass index (BMI) z‐score, and (D) waist circumference (WC). BMI, Body mass index; WC, Waist circumference; WMD, weighted mean difference.
FIGURE 4
FIGURE 4
Forest plots from the meta‐analysis of clinical trials investigating the effects of weight loss interventions on (A) total cholesterol (TC), (B) low‐density lipoprotein cholesterol (LDL‐C), (C) high‐density lipoprotein (HDL), and (D) triglyceride (TG). HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride; WMD, weighted mean difference.
FIGURE 5
FIGURE 5
Forest plots from the meta‐analysis of clinical trials investigating the effects of weight loss interventions on (A) alanine transaminase (ALT), (B) aspartate transaminase (AST), and (C) hepatic steatosis (HS) grade. ALT, alanine transaminase; AST, aspartate transaminase; WMD, weighted mean difference.

Similar articles

Cited by

References

    1. Prasomthong J, Limpeanchob N, Daodee S, Chonpathompikunlert P, Tunsophon S. Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS‐1/Akt and Nrf2 signaling pathways in rats fed a high fat diet. Sci Rep. 2022;12(1):7022. 10.1038/s41598-022-11027-9 - DOI - PMC - PubMed
    1. Furthner D, Weghuber D, Dalus C, et al. Nonalcoholic fatty liver disease in children with obesity: narrative review and research gaps. Horm Res Paediatr. 2022;95(2):167‐176. PubMed PMID: 34351306. Epub 2021/08/06. eng. 10.1159/000518595 - DOI - PubMed
    1. Benítez VC, Alberti G, Uauy R, et al. Childhood Obesity: A Risk Factor for Non‐alcoholic Fatty Liver Disease in Adolescence; 2019.
    1. Salman MA, Mikhail HMS, Nafea MA, et al. Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child‐A NASH‐related cirrhosis. Surg Endosc. 2021;35(3):1269‐1277. 10.1007/s00464-020-07498-4 - DOI - PubMed
    1. Katsagoni CN, Papachristou E, Sidossis A, Sidossis LJN. Effects of dietary and lifestyle interventions on liver, clinical and metabolic parameters in children and adolescents with non‐alcoholic fatty liver disease: A systematic review. Nutrients 2020;12(9):2864. 10.3390/nu12092864 - DOI - PMC - PubMed

LinkOut - more resources